Study protocol for a randomised trial of nicotine-free cigarettes as an adjunct to usual NRT-based cessation practice, in people who wish to stop smoking

BMC Public Health

Study Protocol

Marewa Glover¹  Robyn Whittaker²  Chris Bullen²  Colin Howe²  Natalie K Walker²  Hayden McRobbie³  Murray Laugesen⁴  Stephen Vander Hoorn⁵  Michele Grigg⁶ 

[1] Centre for Tobacco Control Research, Social & Community Health, School of Population Health, The University of Auckland, Private Bag 92019, 1142, Auckland, New Zealand;Clinical Trials Research Unit, School of Population Health, The University of Auckland, Private Bag 92019, 1142, Auckland, New Zealand;Clinical Trials Research Unit, School of Population Health, The University of Auckland, Private Bag 92019, Auckland, New Zealand;Queen Mary University of London, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Charterhouse Square, EC1M 6BQ, London, UK;Health NZ Ltd., 36 Winchester St, 8082, Lyttelton, Christchurch, New Zealand;Statistics Department, The University of Auckland, Private Bag 92019, 1142, Auckland, New Zealand;The Quit Group, PO Box 12605, Wellington, New Zealand;Litmus, Wellington, New Zealand;

关键词: Nicotine;    Nicotine Dependence;    Nicotine Replacement Therapy;    Varenicline;    Nicotine Content;   

DOI  :  10.1186/1471-2458-11-37

 received in 2010-12-14, accepted in 2011-01-14,  发布年份 2011

来源: Springer

【 摘 要 】

BackgroundCurrent smoking cessation treatments focus on addressing the pharmacological dependence of smokers on nicotine. However, new strategies are needed that address both nicotine dependence and the psychological dependence on cigarettes as the source of nicotine. Evidence from a number of small smoking cessation studies suggests that the use of cigarettes with reduced nicotine content, in combination with nicotine replacement therapy (NRT), may help reduce withdrawal symptoms and increase quit rates. This paper describes the protocol for a large randomised-controlled trial to test the effect of using nicotine-free cigarettes together with NRT on long-term quit rates.Methods/designThis single-blind, randomised trial aims to recruit 1,410 participants through the national telephone-based Quitline service in New Zealand. Participants in the treatment arm will be asked to stop smoking nicotine-containing cigarettes on their chosen Quit day and smoke ad libitum nicotine-free (Quest 3) cigarettes for six weeks. At the same time people in this group will be asked to start using NRT patches, gum and/or lozenges (as recommended by Quitline) for eight weeks. Participants in the control arm will be asked to stop smoking completely on their chosen Quit day and start using NRT patches, gum and/or lozenges (as recommended by Quitline) for eight weeks. Data collection will occur at baseline, three and six weeks, and three and six months after Quit day. The primary outcome is the proportion of participants who self-report seven-day point prevalence abstinence at six months since Quit date.DiscussionSmoking prevalence in New Zealand has changed little in recent years (particularly in Māori, the indigenous people of New Zealand) and additional options for smokers who want to quit are needed. Although a variety of methods are available to help, many are expensive, have side effects, and despite their use most quit attempts still fail. This trial will test the balance of benefits and risks of a new strategy for people to overcome nicotine dependence. Since smoking is the leading cause of lost healthy life years in New Zealand, if proven effective this strategy is likely to have substantial public health benefits.Trial registrationAustralia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12608000410358

【 授权许可】

CC BY   
© Walker et al; licensee BioMed Central Ltd. 2011